123 related articles for article (PubMed ID: 12146153)
1. [Sentinel node biopsy in breast cancer. Will this lead to the end of lymphadenectomy for small tumors without suspected axillary adenopathy?].
Garbay JR; Guinebrètiere JM; Mathieu MC; Rochard F
Gynecol Obstet Fertil; 2002 Jun; 30(6):514-22. PubMed ID: 12146153
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
3. Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer.
Schlag PM; Bembenek A
Recent Results Cancer Res; 2000; 157():228-36. PubMed ID: 10857176
[TBL] [Abstract][Full Text] [Related]
4. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
[TBL] [Abstract][Full Text] [Related]
5. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates.
McCready DR; Yong WS; Ng AK; Miller N; Done S; Youngson B
J Natl Cancer Inst; 2004 Jun; 96(11):873-5. PubMed ID: 15173271
[TBL] [Abstract][Full Text] [Related]
6. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy.
Chung MA; Steinhoff MM; Cady B
Am J Surg; 2002 Oct; 184(4):310-4. PubMed ID: 12383890
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
10. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
[TBL] [Abstract][Full Text] [Related]
11. [How to avoid the uncertainties of intraoperative examination of the sentinel lymph node in breast cancer?].
Aubard Y; Mollard J; Fermeaux V
Gynecol Obstet Fertil; 2004 Nov; 32(11):981-4. PubMed ID: 15567689
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
13. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
14. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR
Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737
[TBL] [Abstract][Full Text] [Related]
16. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer.
Balch GC; Mithani SK; Richards KR; Beauchamp RD; Kelley MC
Ann Surg Oncol; 2003 Jul; 10(6):616-21. PubMed ID: 12839845
[TBL] [Abstract][Full Text] [Related]
18. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
Haigh PI; Hansen NM; Qi K; Giuliano AE
Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
[TBL] [Abstract][Full Text] [Related]
19. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy.
Yu JC; Hsu GC; Hsieh CB; Yu CP; Chao TY
Ann Surg Oncol; 2007 Jan; 14(1):174-80. PubMed ID: 17066228
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]